Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Supreme Court ruling broadens BRCA testing options.

Azvolinsky A.

J Natl Cancer Inst. 2013 Nov 20;105(22):1671-2. doi: 10.1093/jnci/djt342. Epub 2013 Nov 6. No abstract available.

PMID:
24198329
2.

Supreme Court will rule on whether patents for BRAC1 and BRAC2 genes are valid.

Dyer C.

BMJ. 2012 Dec 5;345:e8266. doi: 10.1136/bmj.e8266. No abstract available.

PMID:
23223689
3.

[The Supreme Court free genes - economic and legal justifications - impacts on innovation and the healthcare offer].

Cassier M, Stoppa-Lyonnet D.

Med Sci (Paris). 2015 Feb;31(2):209-13. doi: 10.1051/medsci/20153102019. Epub 2015 Mar 4. French. No abstract available.

4.

Gene patenting--is the pendulum swinging back?

Kesselheim AS, Mello MM.

N Engl J Med. 2010 May 20;362(20):1855-8. doi: 10.1056/NEJMp1004026. Epub 2010 Apr 7. No abstract available.

PMID:
20375396
5.

Data disclosure crucial after DNA patent verdict.

de Costa A.

Science. 2013 Aug 30;341(6149):959. doi: 10.1126/science.341.6149.959-a. No abstract available.

PMID:
23990544
6.

US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes.

Dyer C.

BMJ. 2012 Oct 2;345:e6624. doi: 10.1136/bmj.e6624. No abstract available.

PMID:
23033368
7.

Gene patenting--the Supreme Court finally speaks.

Kesselheim AS, Cook-Deegan RM, Winickoff DE, Mello MM.

N Engl J Med. 2013 Aug 29;369(9):869-75. doi: 10.1056/NEJMhle1308199. Epub 2013 Jul 10. No abstract available.

8.

US Supreme Court hears arguments in case of BRCA1 and BRCA2 [corrected] patents.

McCarthy M.

BMJ. 2013 Apr 17;346:f2446. doi: 10.1136/bmj.f2446. No abstract available. Erratum in: BMJ. 2013;346:f2543.

PMID:
23596230
9.

The Supremes got it right.

Somberg J.

Am J Ther. 2013 Jul-Aug;20(4):315. doi: 10.1097/MJT.0b013e3182a10aac. No abstract available.

PMID:
23838630
10.

After the Myriad decision: do hurdles remain for diagnostics competition?

Waller PR, Young DW.

MLO Med Lab Obs. 2013 Sep;45(9):46. No abstract available.

PMID:
24147337
11.

Patents on breast cancer genes are illegal and stymie research, say scientists.

Lenzer J.

BMJ. 2009 Nov 17;339:b4899. doi: 10.1136/bmj.b4899. No abstract available.

PMID:
19920010
12.

BRCA patent dispute may head to US Supreme Court.

Devi S.

Lancet. 2012 Jan 28;379(9813):300. No abstract available.

PMID:
22292161
13.

Intellectual property. In a flurry of metaphors, justices debate a limit on gene patents.

Marshall E.

Science. 2013 Apr 26;340(6131):421. doi: 10.1126/science.340.6131.421. No abstract available.

PMID:
23620028
14.

Ruling on BRCA gene patents could have limited impact.

Goozner M.

J Natl Cancer Inst. 2010 Jun 2;102(11):754-7. doi: 10.1093/jnci/djq209. Epub 2010 May 24. No abstract available.

PMID:
20498427
15.

U.S. Supreme Court decision paves way for better genetic testing: ruling bars exclusive licensing, patents on naturally occurring genes.

Levenson D.

Am J Med Genet A. 2013 Sep;161A(9):ix-x. doi: 10.1002/ajmg.a.36167. No abstract available.

PMID:
23946205
16.

Who owns human genes?: Is DNA patentable?

Gostin LO.

JAMA. 2013 Aug 28;310(8):791-2. No abstract available.

PMID:
23877839
17.

Intellectual property. Supreme Court rules out patents on 'natural' genes.

Marshall E.

Science. 2013 Jun 21;340(6139):1387-8. doi: 10.1126/science.340.6139.1387. No abstract available. Erratum in: Science. 2013 Aug 23;341(6148):842.

PMID:
23788772
18.
19.

Myriad Genetics embroiled in breast-cancer data fight - again.

Check Hayden E.

Nature. 2016 May 26;533(7604):449. doi: 10.1038/nature.2016.19953. No abstract available.

PMID:
27225096
20.

Genes can't be patented, rules Supreme Court.

McCarthy M.

BMJ. 2013 Jun 14;346:f3907. doi: 10.1136/bmj.f3907. No abstract available.

PMID:
23771229

Supplemental Content

Support Center